newsfilter
← Latest News
GlobeNewswire·

Mindset Pharma CEO, James Lanthier Issues Letter to Shareholders

TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE:MSET) (FSE: 9DF) (OTCQB:MSSTF) ("Mindset" or the "Company") today issued a letter to shareholders from James Lanthier, Chief Executive Officer of